DNAPrint Genomics Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2002
2003
2004
2005
2006
Net Income before Extraordinaries
3,113.60
7,789.90
3,735.00
8,715.90
12,348.40
Depreciation, Depletion & Amortization
179.10
125.60
182.80
224.10
539.60
Other Funds
85.00
238.20
-
135.00
-
Funds from Operations
1,976.50
1,615.00
2,656.10
4,191.10
8,131.20
Changes in Working Capital
405.10
85.20
1,108.40
585.20
2,349.40
Net Operating Cash Flow
1,571.40
1,529.80
3,764.40
3,605.90
5,781.80
Capital Expenditures
16.50
14.20
57.00
123.60
391.40
Sale of Fixed Assets & Businesses
10.10
-
-
-
-
Purchase/Sale of Investments
-
-
-
-
554.60
Net Investing Cash Flow
6.40
14.20
250.70
2,195.90
163.20
Issuance/Reduction of Debt, Net
1,165.50
653.50
148.60
2,301.70
1,371.40
Net Financing Cash Flow
1,546.50
1,798.10
4,727.70
6,630.00
4,405.20
Net Change in Cash
31.20
254.10
712.60
828.10
1,212.00
Free Cash Flow
1,587.80
1,544.00
3,821.40
3,729.50
6,173.20
Net Assets from Acquisitions
-
-
-
2,274.70
-
Other Sources
-
-
-
202.40
-
Change in Capital Stock
296.00
906.50
4,876.30
4,463.20
3,033.80
Exchange Rate Effect
-
-
-
0.10
1.40
Other Uses
-
-
193.70
-
-
Miscellaneous Funds
0.00
-
-
0.00
0.00
About DNAPrint Genomics
View Profile
